Safety and Efficacy of Remote Ischemic Conditioning Treatment for Community-based Essential Hypertension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-75
SponsorYi Yang

About this trial

The purpose of this study is to explore the efficacy and safety of remote ischemic conditioning for essential hypertension in the community population.

Eligibility criteria

Qualifiers

Age≥30 years, ≤ 75 years, regardless of sex;

Patients with a history of essential hypertension and systolic blood pressure (SBP) ≥140 mmHg in three blood pressure measurements performed on separate days within 3 days prior to enrollment.

Signed and dated informed consent is obtained.

Disqualifiers

Blood pressure ≥ 180/110mmHg;

Planned adjustment of antihypertensive drugs within the next 3 weeks;

Severe hematologic disorders or significant coagulation abnormalities;

Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;

Trial design

Treatments tested in this trial

  • Patients are treated with previous antihypertensive treatment plus remote ischemic conditioning.
  • Previous antihypertensive treatment

Treatment groups

500 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Yi Yang

Lead sponsor

The First Hospital of Jilin University

Sponsor institution